The PCa patients with the TT genotype had a median PSA level that was 12 fold higher than that in the control subjects with the TT genotype, whereas PCa patients with the TC or CC genotype had a median PSA level that was 9 fold higher than that in their counterparts in the control group. This evidence concerns the gene KLK3 and posterior cortical atrophy.